Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Sep
30
2009
OTC Drug and Dietary Supplement Labeling: Adverse Event Reporting Information Sheppard, Mullin, Richter & Hampton LLP
May
8
2021
FDA Proposes Risk-Based and Remote Inspection Strategies in New Report Sheppard, Mullin, Richter & Hampton LLP
Jul
19
2018
340B Drug Pricing Program Litigation Update: American Hospital Association, Et Al. v. Azar Sheppard, Mullin, Richter & Hampton LLP
Apr
18
2014
Review – U.S. Patent and Trademark Office Subject Matter Eligibility Guidelines Sheppard, Mullin, Richter & Hampton LLP
Aug
25
2022
Healthcare Reforms Under the IRA: Expanding Access to Care Sheppard, Mullin, Richter & Hampton LLP
Dec
5
2014
Now That That’s Settled: The Status of Class Action Settlements in the Seventh Circuit after Pella, Radioshack and NBTY Sheppard, Mullin, Richter & Hampton LLP
Mar
17
2015
California Federal Court Finds that Class Action Plaintiffs’ False Advertising Claims are Stripped Bayer Based on Federal Preemption Sheppard, Mullin, Richter & Hampton LLP
Mar
20
2023
FDA Draft Guidance Signifies Acceptance of the Term “Milk” to Describe Plant-Based Alternatives Sheppard, Mullin, Richter & Hampton LLP
Aug
28
2015
What’s in a Name? That Which We Call a Biological Product… Sheppard, Mullin, Richter & Hampton LLP
Jan
19
2016
Extending Patentable Life of 3D Printers: Lesson From Pharmaceutical Industry Sheppard, Mullin, Richter & Hampton LLP
Jan
22
2020
New Jersey Court Commands Cannabis Reimbursement in Workers’ Compensation Dispute Sheppard, Mullin, Richter & Hampton LLP
Apr
7
2020
Nota Bene Episode 73: “Quarantine and Chill”: Will COVID-19 Impact the Cannabis Industry? with Whitney Hodges Sheppard, Mullin, Richter & Hampton LLP
Jan
21
2024
FDA Issues Final Rule and Guidance on Direct-To-Consumer Prescription Drug Advertisements Sheppard, Mullin, Richter & Hampton LLP
Jun
18
2020
President Of Medical Technology Company Charged For Promoting Fake COVID-19 Treatment Sheppard, Mullin, Richter & Hampton LLP
Apr
3
2024
FTC’s Campaign Against Improper Orange Book Listings Continues with Amicus Brief in Teva’s Challenge of Amneal Asthma Inhaler ANDA Sheppard, Mullin, Richter & Hampton LLP
Aug
19
2020
President Trump’s Executive Order Mandating the Purchase of U.S. Drugs Evokes Criticism Sheppard, Mullin, Richter & Hampton LLP
May
7
2024
Cannabis Operator Challenges California State Statute and Regulations Requiring Labor Peace Agreements Sheppard, Mullin, Richter & Hampton LLP
Oct
2
2020
FDA’s Proposed Rule on “Intended Use” Confirms Agency Will Rely on “Any Relevant Source” of Evidence Sheppard, Mullin, Richter & Hampton LLP
Dec
4
2020
Cannabis Gets Go-Ahead from House, But Still Faces Hurdles Before Federal Legalization Sheppard, Mullin, Richter & Hampton LLP
Jul
10
2017
Giving Telemedicine More Room to Breathe: Recent and Pending State and Federal Actions in the World of Online Prescribing Sheppard, Mullin, Richter & Hampton LLP
Oct
3
2013
The Food and Drug Administration (FDA) Releases Long-Awaited Final Guidance on Mobile Medical Applications Sheppard, Mullin, Richter & Hampton LLP
Feb
17
2022
FDA Boosts Protein Preemption Defense Sheppard, Mullin, Richter & Hampton LLP
Jun
3
2014
Northern District of California Courts Still Searching for Sweet Spot in “Evaporated Cane Juice” Cases: Confusion Over Applicability of Primary Jurisdiction to ECJ Claims Continues Sheppard, Mullin, Richter & Hampton LLP
Jun
29
2022
California District Court Finds that EKRA Applies to Compensation Methodologies for Labs’ Employed Marketers Who Market to Physicians Sheppard, Mullin, Richter & Hampton LLP
Jul
6
2022
California Governor Signs into Law Cannabis Tax Relief Bill Sheppard, Mullin, Richter & Hampton LLP
Apr
17
2019
New York City Council Passes Legislation Banning Marijuana Testing of Job Applicants Sheppard, Mullin, Richter & Hampton LLP
Apr
22
2019
FDA Issues Warning Letter to Lab Marketing Three Laboratory-Developed Tests Sheppard, Mullin, Richter & Hampton LLP
Nov
4
2014
Mobile Health Apps are in a Boom Phase – Why is it so Hard for Pharmaceutical Companies to Find Users? Sheppard, Mullin, Richter & Hampton LLP
Oct
27
2022
FDA Proposes Updated Rule for “Healthy” Foods Sheppard, Mullin, Richter & Hampton LLP
Jul
29
2019
Delaware Supreme Court Allows Caremark Claim to Proceed Against Directors of Ice Cream Manufacturer Following Listeria Outbreak Sheppard, Mullin, Richter & Hampton LLP
Apr
21
2020
Telehealth and Online Prescribing: COVID-19 Triggers Changes to the Prescriber/Patient/Pharmacist Relationship Sheppard, Mullin, Richter & Hampton LLP
Oct
14
2016
Proposed New FDA Labeling Rules Would Result in Increased Generic Drug Product Liability Claims Sheppard, Mullin, Richter & Hampton LLP
Mar
25
2024
PFAS in Food Packaging: The Beginning of the End? Sheppard, Mullin, Richter & Hampton LLP
Aug
19
2020
Using ADR for Cannabis Disputes Sheppard, Mullin, Richter & Hampton LLP
Sep
25
2020
FDA Update: The Latest on Vaccine Development, Inspections, and Conducting Clinical Trials During Covid-19 Sheppard, Mullin, Richter & Hampton LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins